FUJIFILM EC-530HL2Recalls & reported problems
Fujifilm Corporation · This device is intended for the visualization of the lower digestive tract, specifically for the observation, diagnosis, and endoscopic treatment of the rectum and large intestine. This device may be used on adults, adolescents and children requiring endoscopic examination and as deemed appropriate by trained medical professionals. · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 04547410323856), received between Jan 23, 2018 and Jan 23, 2018 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Mechanical Problem” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Mechanical Problem4
- Device Reprocessing Problem1
Patient problems
- No Consequences Or Impact To Patient5
- No Known Impact Or Consequence To Patient5
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 23, 2018Device Reprocessing Problem; Device Reprocessing Problem
IN RESPONSE TO THE FDA INSPECTION CONDUCTED IN (B)(4) 2015, A PHASE 1 TWO YEAR RETROSPECTIVE REVIEW ((B)(4) 2013 TO (B)(4) 2015) OF ALL ENDOSCOPE SERVICE WORK ORDERS WAS PERFORMED, IN ORDER TO IDENTIFY AND ASSESS ENDOSCOPE MALFUNCTIONS THAT MAY POTENTIALLY FALL WITHIN THE MDR REPORTABILITY REGULATIONS 21 CFR 803. AS A RESULT OF THAT INITIAL PHASE 1 RETROSPECTIVE REVIEW, MDRS WERE SUBMITTED RETROSPECTIVELY. A PHASE 2 RETROSPECTIVE REVIEW FOR THE PERIOD OF (B)(4) 2015 TO (B)(4) 2016, HAS ALSO BEEN CONDUCTED. AS A RESULT OF THE PHASE 2 REVIEW, IT WAS DETERMINED THAT THE IDENTIFIED MALFUNCTION MAY RESULT IN A WORST CASE SCENARIO AS "FOREIGN MATTER RESIDUE FOUND IN SCOPE CHANNEL/PORT/VALVE CYLINDER ". HOWEVER, BECAUSE THERE IS LITTLE INFORMATION AVAILABLE ON THE UNDERLYING EVENT WHICH LED TO THE REPAIR, THE COMPANY IS UNABLE TO DETERMINE WHETHER THIS MALFUNCTION CAUSED ANY RISK TO A PATIENT. NO KNOWN PATIENT INJURY OR DEATH RESULTED FROM THIS EVENT; THIS MDR IS BEING SUBMITTED IN AN ABUNDANCE OF CAUTION.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7211610 ↗MalfunctionJan 23, 2018Mechanical Problem; Mechanical Problem
IN RESPONSE TO THE FDA INSPECTION CONDUCTED IN (B)(6) 2015, A PHASE 1 TWO YEAR RETROSPECTIVE REVIEW ((B)(6) 2013 TO (B)(6) 2015) OF ALL ENDOSCOPE SERVICE WORK ORDERS WAS PERFORMED IN ORDER TO IDENTIFY AND ASSESS ENDOSCOPE MALFUNCTIONS THAT MAY POTENTIALLY FALL WITHIN THE MDR REPORTABILITY REGULATIONS 21 CFR 803. AS A RESULT OF THAT INITIAL PHASE 1 RETROSPECTIVE REVIEW, MDRS WERE SUBMITTED RETROSPECTIVELY. A PHASE 2 RETROSPECTIVE REVIEW FOR THE PERIOD OF (B)(6) 2015 TO (B)(6) 2016, HAS ALSO BEEN CONDUCTED. AS A RESULT OF THE PHASE 2 REVIEW, IT WAS DETERMINED THAT THE IDENTIFIED MALFUNCTION MAY TRIGGER, IN A WORST CASE SCENARIO THE "BENDING SECTION TO BECOME LOCKED IN A J-SHAPE AND CANNOT BE RELEASED". HOWEVER, BECAUSE THERE IS LIMITED INFORMATION REGARDING THE UNDERLYING EVENT WHICH LED TO THE REPAIR, THE COMPANY IS UNABLE TO DETERMINE WHETHER THE WORST CASE SCENARIO ACTUALLY OCCURRED AND CAUSED ANY RISK TO A PATIENT. NO KNOWN PATIENT INJURY OR DEATH RESULTED FROM THIS EVENT; HOWEVER, THIS MDR IS BEING SUBMITTED IN AN ABUNDANCE OF CAUTION.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7211581 ↗MalfunctionJan 23, 2018Mechanical Problem; Mechanical Problem
IN RESPONSE TO THE FDA INSPECTION CONDUCTED IN APRIL 2015, A PHASE 1 TWO YEAR RETROSPECTIVE REVIEW (AUGUST 1, 2013 TO AUGUST 31, 2015) OF ALL ENDOSCOPE SERVICE WORK ORDERS WAS PERFORMED IN ORDER TO IDENTIFY AND ASSESS ENDOSCOPE MALFUNCTIONS THAT MAY POTENTIALLY FALL WITHIN THE MDR REPORTABILITY REGULATIONS 21 CFR 803. AS A RESULT OF THAT INITIAL PHASE 1 RETROSPECTIVE REVIEW, MDRS WERE SUBMITTED RETROSPECTIVELY. A PHASE 2 RETROSPECTIVE REVIEW FOR THE PERIOD OF SEPTEMBER 1, 2015 TO JULY 31, 2016, HAS ALSO BEEN CONDUCTED. AS A RESULT OF THE PHASE 2 REVIEW, IT WAS DETERMINED THAT THE IDENTIFIED MALFUNCTION MAY TRIGGER, IN A WORST CASE SCENARIO THE "BENDING SECTION TO BECOME LOCKED IN A J-SHAPE AND CANNOT BE RELEASED". HOWEVER, BECAUSE THERE IS LIMITED INFORMATION REGARDING THE UNDERLYING EVENT WHICH LED TO THE REPAIR, THE COMPANY IS UNABLE TO DETERMINE WHETHER THE WORST CASE SCENARIO ACTUALLY OCCURRED AND CAUSED ANY RISK TO A PATIENT. NO KNOWN PATIENT INJURY OR DEATH RESULTED FROM THIS EVENT; HOWEVER, THIS MDR IS BEING SUBMITTED IN AN ABUNDANCE OF CAUTION.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7211576 ↗MalfunctionJan 23, 2018Mechanical Problem; Mechanical Problem
IN RESPONSE TO THE FDA INSPECTION CONDUCTED IN APRIL 2015, A PHASE 1 TWO YEAR RETROSPECTIVE REVIEW (AUGUST 1, 2013 TO AUGUST 31, 2015) OF ALL ENDOSCOPE SERVICE WORK ORDERS WAS PERFORMED IN ORDER TO IDENTIFY AND ASSESS ENDOSCOPE MALFUNCTIONS THAT MAY POTENTIALLY FALL WITHIN THE MDR REPORTABILITY REGULATIONS 21 CFR 803. AS A RESULT OF THAT INITIAL PHASE 1 RETROSPECTIVE REVIEW, MDRS WERE SUBMITTED RETROSPECTIVELY. A PHASE 2 RETROSPECTIVE REVIEW FOR THE PERIOD OF SEPTEMBER 1, 2015 TO JULY 31, 2016, HAS ALSO BEEN CONDUCTED. AS A RESULT OF THE PHASE 2 REVIEW, IT WAS DETERMINED THAT THE IDENTIFIED MALFUNCTION MAY TRIGGER, IN A WORST CASE SCENARIO THE "BENDING SECTION TO BECOME LOCKED IN A J-SHAPE AND CANNOT BE RELEASED". HOWEVER, BECAUSE THERE IS LIMITED INFORMATION REGARDING THE UNDERLYING EVENT WHICH LED TO THE REPAIR, THE COMPANY IS UNABLE TO DETERMINE WHETHER THE WORST CASE SCENARIO ACTUALLY OCCURRED AND CAUSED ANY RISK TO A PATIENT. NO KNOWN PATIENT INJURY OR DEATH RESULTED FROM THIS EVENT; HOWEVER, THIS MDR IS BEING SUBMITTED IN AN ABUNDANCE OF CAUTION.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7211575 ↗MalfunctionJan 23, 2018Mechanical Problem; Mechanical Problem
IN RESPONSE TO THE FDA INSPECTION CONDUCTED IN APRIL 2015, A PHASE 1 TWO YEAR RETROSPECTIVE REVIEW (AUGUST 1, 2013 TO AUGUST 31, 2015) OF ALL ENDOSCOPE SERVICE WORK ORDERS WAS PERFORMED IN ORDER TO IDENTIFY AND ASSESS ENDOSCOPE MALFUNCTIONS THAT MAY POTENTIALLY FALL WITHIN THE MDR REPORTABILITY REGULATIONS 21 CFR 803. AS A RESULT OF THAT INITIAL PHASE 1 RETROSPECTIVE REVIEW, MDRS WERE SUBMITTED RETROSPECTIVELY. A PHASE 2 RETROSPECTIVE REVIEW FOR THE PERIOD OF SEPTEMBER 1, 2015 TO JULY 31, 2016, HAS ALSO BEEN CONDUCTED. AS A RESULT OF THE PHASE 2 REVIEW, IT WAS DETERMINED THAT THE IDENTIFIED MALFUNCTION MAY TRIGGER, IN A WORST CASE SCENARIO THE "BENDING SECTION TO BECOME LOCKED IN A J-SHAPE AND CANNOT BE RELEASED". HOWEVER, BECAUSE THERE IS LIMITED INFORMATION REGARDING THE UNDERLYING EVENT WHICH LED TO THE REPAIR, THE COMPANY IS UNABLE TO DETERMINE WHETHER THE WORST CASE SCENARIO ACTUALLY OCCURRED AND CAUSED ANY RISK TO A PATIENT. NO KNOWN PATIENT INJURY OR DEATH RESULTED FROM THIS EVENT; HOWEVER, THIS MDR IS BEING SUBMITTED IN AN ABUNDANCE OF CAUTION.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7211569 ↗
Other Colonoscope and accessories, flexible/rigid devices
- EVIS EXERA lll COLONOVIDEOSCOPE OLYMPUS CF-HQ190LOlympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid3 recalls2 deaths6,804 reports
- EVIS EXERA III XENON LIGHT SOURCE OLYMPUS CLV-190Olympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid6,617 reports
- EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE OLYMPUS GIF-HQ190Olympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid3 recalls5 deaths6,244 reports
- EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE OLYMPUS GIF-H190Olympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid2 recalls7 deaths5,572 reports
- EVIS EXERA III COLONOVIDEOSCOPE OLYMPUS PCF-H190DLOlympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid3 recalls2,830 reports
- EVIS EXERA lll COLONOVIDEOSCOPE OLYMPUS PCF-H190LOlympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid3 recalls2 deaths2,513 reports
- EVIS EXERA lll COLONOVIDEOSCOPE OLYMPUS CF-H190IOlympus Medical Systems Corp. · Colonoscope and accessories, flexible/rigid1 recall1,967 reports
- PENTAX Medical EC38-i10cLHoya Corporation · Colonoscope and accessories, flexible/rigid1,618 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page